Strs Ohio cut its holdings in shares of RadNet, Inc. (NASDAQ:RDNT) by 26.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,000 shares of the medical research company’s stock after selling 23,100 shares during the period. Strs Ohio owned about 0.13% of RadNet worth $727,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Susquehanna International Group LLP lifted its stake in RadNet by 336.0% during the second quarter. Susquehanna International Group LLP now owns 33,043 shares of the medical research company’s stock worth $256,000 after purchasing an additional 47,043 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in RadNet by 6.4% during the second quarter. The Manufacturers Life Insurance Company now owns 33,305 shares of the medical research company’s stock worth $258,000 after purchasing an additional 1,997 shares during the last quarter. State Street Corp lifted its stake in RadNet by 9.2% during the second quarter. State Street Corp now owns 585,218 shares of the medical research company’s stock worth $4,538,000 after purchasing an additional 49,186 shares during the last quarter. Cornerstone Capital Management Holdings LLC. lifted its stake in RadNet by 104.4% during the second quarter. Cornerstone Capital Management Holdings LLC. now owns 102,000 shares of the medical research company’s stock worth $789,000 after purchasing an additional 52,099 shares during the last quarter. Finally, Parallax Volatility Advisers L.P. lifted its stake in RadNet by 122.0% during the second quarter. Parallax Volatility Advisers L.P. now owns 21,122 shares of the medical research company’s stock worth $164,000 after purchasing an additional 117,148 shares during the last quarter. Hedge funds and other institutional investors own 48.61% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Strs Ohio Sells 23,100 Shares of RadNet, Inc. (RDNT)” was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.watchlistnews.com/strs-ohio-sells-23100-shares-of-radnet-inc-rdnt/1685089.html.

Shares of RadNet, Inc. (NASDAQ:RDNT) opened at $10.60 on Tuesday. The firm has a market capitalization of $501.02, a price-to-earnings ratio of 48.18 and a beta of 0.87. RadNet, Inc. has a 1-year low of $5.25 and a 1-year high of $11.90. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 9.45.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings data on Tuesday, August 8th. The medical research company reported $0.11 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.04 by $0.07. The business had revenue of $230.00 million during the quarter, compared to the consensus estimate of $230.32 million. RadNet had a return on equity of 19.98% and a net margin of 1.04%. RadNet’s quarterly revenue was up 5.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.09 earnings per share. equities analysts anticipate that RadNet, Inc. will post 0.36 EPS for the current fiscal year.

In other RadNet news, VP Mark Stolper sold 10,000 shares of the stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $10.19, for a total transaction of $101,900.00. Following the completion of the sale, the vice president now directly owns 145,319 shares in the company, valued at approximately $1,480,800.61. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, major shareholder Sandy Nyholm Kaminsky sold 1,100,000 shares of the stock in a transaction dated Tuesday, October 3rd. The stock was sold at an average price of $10.95, for a total value of $12,045,000.00. The disclosure for this sale can be found here. Insiders sold 1,236,900 shares of company stock valued at $13,452,504 over the last 90 days. 9.36% of the stock is currently owned by company insiders.

Several research firms have weighed in on RDNT. Zacks Investment Research cut RadNet from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. TheStreet downgraded shares of RadNet from a “b-” rating to a “c” rating in a report on Friday, October 27th. BidaskClub upgraded shares of RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. Finally, Jefferies Group LLC upgraded shares of RadNet from a “hold” rating to a “buy” rating and upped their price target for the stock from $7.00 to $12.00 in a report on Tuesday, August 22nd. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. RadNet has an average rating of “Buy” and an average target price of $12.00.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNT).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.